News/ News/ Oncology/ R&D/ UK & Europe Following FDA encouragement, Faron’s orphan drug gets UK special designation Andrew McConaghie European biotech, Faron pharmaceuticals 0 Comment Faron Pharmaceuticals has been granted a Promising Innovative Medicines (PIM) designation in the UK for its lead product Share X Following FDA encouragement, Faron’s orphan drug gets UK special designation https://pharmaphorum.com/news/following-fda-encouragement-farons-orphan-drug-gets-uk-special-designation/
